Tor1 and CK2 kinases control a switch between alternative ribosome biogenesis pathways in a growth-dependent manner

Isabelle C Kos-Braun1, Ilona Jung1, Martin Koš1

  • 1Biochemistry Center, University of Heidelberg, Heidelberg, Germany.

Plos Biology
|March 11, 2017
PubMed

Insights

The Target of rapamycin 1 (Tor1) pathway controls ribosome production during stress. This study reveals Tor1 and casein kinase 2 (CK2) regulate pre-ribosomal RNA processing post-transcriptionally, halting new ribosome synthesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Ribosome biogenesis is a critical, energy-intensive cellular process.
  • The Target of rapamycin 1 (Tor1) pathway is known to regulate ribosomal RNA (rRNA) synthesis transcriptionally.
  • The posttranscriptional regulation of ribosome biogenesis remains largely uncharacterized.

Purpose of the Study:

  • To investigate the posttranscriptional control mechanisms of ribosome biogenesis.
  • To determine the role of Tor1 and casein kinase 2 (CK2) in regulating pre-ribosomal RNA (pre-rRNA) processing.
  • To identify novel signaling pathways involved in ribosome biogenesis regulation under stress conditions.

Main Methods:

  • Utilized yeast as a model organism.
  • Investigated the effects of Tor1 and CK2 kinases on pre-rRNA processing pathways.
  • Analyzed the role of Sch9 kinase in the stress-induced regulation of ribosome biogenesis.

Main Results:

  • Demonstrated that Tor1 and CK2 kinases control a rapid switch in pre-rRNA processing pathways in yeast.
  • Showed that under stress, pre-rRNA synthesis continues but is processed into non-productive forms, halting ribosome production.
  • Found that this regulatory switch is independent of Sch9 kinase activity.

Conclusions:

  • Identified a novel TOR Complex 1 (TORC1) signaling pathway involving CK2 that directly regulates ribosome biogenesis at the posttranscriptional level.
  • Established that Tor1 and CK2 kinases mediate a rapid response to cellular stress by altering pre-rRNA processing.
  • Highlighted a previously unrecognized mechanism for controlling ribosome production independent of transcriptional regulation and Sch9 kinase.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
9.9K
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
422
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.8K